Cargando…

Quality of evidence supporting Surviving Sepsis Campaign Recommendations

INTRODUCTION: The Surviving Sepsis Campaign (SSC) guidelines, released in 2017, are a combination of expert opinion and evidence-based medicine, adopted by many institutions as a standard of practice. The aim was to analyse the quality of evidence supporting recommendations on the management of seps...

Descripción completa

Detalles Bibliográficos
Autores principales: Rello, Jordi, Tejada, Sofia, Xu, Elena, Solé-Lleonart, Candela, Campogiani, Laura, Koulenti, Despoina, Ferreira-Coimbra, João, Lipman, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340061/
https://www.ncbi.nlm.nih.gov/pubmed/32650126
http://dx.doi.org/10.1016/j.accpm.2020.06.015
_version_ 1783554986716692480
author Rello, Jordi
Tejada, Sofia
Xu, Elena
Solé-Lleonart, Candela
Campogiani, Laura
Koulenti, Despoina
Ferreira-Coimbra, João
Lipman, Jeff
author_facet Rello, Jordi
Tejada, Sofia
Xu, Elena
Solé-Lleonart, Candela
Campogiani, Laura
Koulenti, Despoina
Ferreira-Coimbra, João
Lipman, Jeff
author_sort Rello, Jordi
collection PubMed
description INTRODUCTION: The Surviving Sepsis Campaign (SSC) guidelines, released in 2017, are a combination of expert opinion and evidence-based medicine, adopted by many institutions as a standard of practice. The aim was to analyse the quality of evidence supporting recommendations on the management of sepsis. METHODS: The strength and quality of evidence (high, moderate, low-very low and best practice statements) of each recommendation were extracted. Randomised controlled trials were required to qualify as high-quality evidence. RESULTS: A total of 96 recommendations were formulated, and 87 were included. Among thirty-one (43%) strong recommendations, only 15.2% were supported by high-quality evidence. Overall, thirty-seven (42.5%) recommendations were based on low-quality evidence, followed by 28 (32.2%) based on moderate-quality, 15 (17.2%) were best practice statements and only seven (8.0%) were supported by high-quality evidence. Randomised controlled trials supported 21.4%, 9.5% and 8.6% recommendations on mechanical ventilation, resuscitation, and management/adjuvant therapy, respectively. In contrast, none high-quality evidence recommendation supported antimicrobial/source control (82.4% were low-very low evidence or best practice statements), and nutrition. CONCLUSIONS: In the SSC guidelines most recommendations were informed by indirect evidence and non-systematic observations. While awaiting trials results, Delphi-like approaches or multi-criteria decision analyses should guide recommendations.
format Online
Article
Text
id pubmed-7340061
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-73400612020-07-07 Quality of evidence supporting Surviving Sepsis Campaign Recommendations Rello, Jordi Tejada, Sofia Xu, Elena Solé-Lleonart, Candela Campogiani, Laura Koulenti, Despoina Ferreira-Coimbra, João Lipman, Jeff Anaesth Crit Care Pain Med Article INTRODUCTION: The Surviving Sepsis Campaign (SSC) guidelines, released in 2017, are a combination of expert opinion and evidence-based medicine, adopted by many institutions as a standard of practice. The aim was to analyse the quality of evidence supporting recommendations on the management of sepsis. METHODS: The strength and quality of evidence (high, moderate, low-very low and best practice statements) of each recommendation were extracted. Randomised controlled trials were required to qualify as high-quality evidence. RESULTS: A total of 96 recommendations were formulated, and 87 were included. Among thirty-one (43%) strong recommendations, only 15.2% were supported by high-quality evidence. Overall, thirty-seven (42.5%) recommendations were based on low-quality evidence, followed by 28 (32.2%) based on moderate-quality, 15 (17.2%) were best practice statements and only seven (8.0%) were supported by high-quality evidence. Randomised controlled trials supported 21.4%, 9.5% and 8.6% recommendations on mechanical ventilation, resuscitation, and management/adjuvant therapy, respectively. In contrast, none high-quality evidence recommendation supported antimicrobial/source control (82.4% were low-very low evidence or best practice statements), and nutrition. CONCLUSIONS: In the SSC guidelines most recommendations were informed by indirect evidence and non-systematic observations. While awaiting trials results, Delphi-like approaches or multi-criteria decision analyses should guide recommendations. Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2020-08 2020-07-07 /pmc/articles/PMC7340061/ /pubmed/32650126 http://dx.doi.org/10.1016/j.accpm.2020.06.015 Text en © 2020 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rello, Jordi
Tejada, Sofia
Xu, Elena
Solé-Lleonart, Candela
Campogiani, Laura
Koulenti, Despoina
Ferreira-Coimbra, João
Lipman, Jeff
Quality of evidence supporting Surviving Sepsis Campaign Recommendations
title Quality of evidence supporting Surviving Sepsis Campaign Recommendations
title_full Quality of evidence supporting Surviving Sepsis Campaign Recommendations
title_fullStr Quality of evidence supporting Surviving Sepsis Campaign Recommendations
title_full_unstemmed Quality of evidence supporting Surviving Sepsis Campaign Recommendations
title_short Quality of evidence supporting Surviving Sepsis Campaign Recommendations
title_sort quality of evidence supporting surviving sepsis campaign recommendations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340061/
https://www.ncbi.nlm.nih.gov/pubmed/32650126
http://dx.doi.org/10.1016/j.accpm.2020.06.015
work_keys_str_mv AT rellojordi qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT tejadasofia qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT xuelena qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT solelleonartcandela qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT campogianilaura qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT koulentidespoina qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT ferreiracoimbrajoao qualityofevidencesupportingsurvivingsepsiscampaignrecommendations
AT lipmanjeff qualityofevidencesupportingsurvivingsepsiscampaignrecommendations